Insights into the molecular mechanisms and nanoparticle-based therapies for gastric cancer: A review

Gastric cancer is characterized by the abnormal development of cells in the intestinal lining and is listed as the third leading cause of cancer-related deaths globally. Accurate detection continues to be difficult and conventional therapies, such as radiation, surgery, and chemotherapy, frequently...

Full description

Saved in:
Bibliographic Details
Main Authors: Smarika Chauhan, Eswar Marcharla, Sneha Hariharan, Saranya Vinayagam, Thanigaivel Sundaram, Priya SD, Swamynathan Ganesan, Maximilian Lackner
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Results in Engineering
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S259012302500324X
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825199441949229056
author Smarika Chauhan
Eswar Marcharla
Sneha Hariharan
Saranya Vinayagam
Thanigaivel Sundaram
Priya SD
Swamynathan Ganesan
Maximilian Lackner
author_facet Smarika Chauhan
Eswar Marcharla
Sneha Hariharan
Saranya Vinayagam
Thanigaivel Sundaram
Priya SD
Swamynathan Ganesan
Maximilian Lackner
author_sort Smarika Chauhan
collection DOAJ
description Gastric cancer is characterized by the abnormal development of cells in the intestinal lining and is listed as the third leading cause of cancer-related deaths globally. Accurate detection continues to be difficult and conventional therapies, such as radiation, surgery, and chemotherapy, frequently encounter problems with poor absorption, toxicity, and a lack of specificity. This review aims to explore the role of nanoparticles in the prognosis and diagnosis of gastric cancer. We have analysed genomic pathways linked with gastric carcinoma and explored the utilisation of nanoparticles for multimodal imaging techniques, precise drug delivery and efficient therapeutic approaches. The use of nanoparticles has the advantage of increasing the effectiveness of treatment outcomes while reducing side effects. Moreover, they enable early detection through highly sensitive imaging techniques, improving the accuracy of diagnosis and disease monitoring. Nanoparticles enhance drug delivery in gastric cancer by enabling precise delivery to tumor sites, improving therapeutic precision, and reducing side effects. They also boost therapy outcomes by overcoming chemotherapy resistance and enabling co-delivery of multiple drugs. Preclinical studies indicate that treatments using nanoparticles demonstrated an increase in early detection and rise in treating diseases compared to traditional therapies. In summary, nanotechnology offers a promising approach in detecting and managing gastric cancer by providing highly efficient and minimally invasive techniques. Integrating nanoparticles into clinical practice can effectively address the limitations of current therapies and significantly improve patient outcomes.
format Article
id doaj-art-aa120649d63c41cfb0c8e66c41417282
institution Kabale University
issn 2590-1230
language English
publishDate 2025-03-01
publisher Elsevier
record_format Article
series Results in Engineering
spelling doaj-art-aa120649d63c41cfb0c8e66c414172822025-02-08T05:00:59ZengElsevierResults in Engineering2590-12302025-03-0125104238Insights into the molecular mechanisms and nanoparticle-based therapies for gastric cancer: A reviewSmarika Chauhan0Eswar Marcharla1Sneha Hariharan2Saranya Vinayagam3Thanigaivel Sundaram4Priya SD5Swamynathan Ganesan6Maximilian Lackner7Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu District, Tamil Nadu 603203, IndiaDepartment of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu District, Tamil Nadu 603203, IndiaDepartment of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu District, Tamil Nadu 603203, IndiaDepartment of Biosciences, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, Tamil Nadu 602 105, IndiaDepartment of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu District, Tamil Nadu 603203, IndiaInstituto de Alta Investigación, Universidad de Tarapacá, Arica 1000000, ChileDepartment of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu District, Tamil Nadu 603203, India; Corresponding authors.University of Applied Sciences Technikum Wien, Faculty of Industrial Engineering, Hoechstaedtplatz 6, 1200 Vienna, Austria; Corresponding authors.Gastric cancer is characterized by the abnormal development of cells in the intestinal lining and is listed as the third leading cause of cancer-related deaths globally. Accurate detection continues to be difficult and conventional therapies, such as radiation, surgery, and chemotherapy, frequently encounter problems with poor absorption, toxicity, and a lack of specificity. This review aims to explore the role of nanoparticles in the prognosis and diagnosis of gastric cancer. We have analysed genomic pathways linked with gastric carcinoma and explored the utilisation of nanoparticles for multimodal imaging techniques, precise drug delivery and efficient therapeutic approaches. The use of nanoparticles has the advantage of increasing the effectiveness of treatment outcomes while reducing side effects. Moreover, they enable early detection through highly sensitive imaging techniques, improving the accuracy of diagnosis and disease monitoring. Nanoparticles enhance drug delivery in gastric cancer by enabling precise delivery to tumor sites, improving therapeutic precision, and reducing side effects. They also boost therapy outcomes by overcoming chemotherapy resistance and enabling co-delivery of multiple drugs. Preclinical studies indicate that treatments using nanoparticles demonstrated an increase in early detection and rise in treating diseases compared to traditional therapies. In summary, nanotechnology offers a promising approach in detecting and managing gastric cancer by providing highly efficient and minimally invasive techniques. Integrating nanoparticles into clinical practice can effectively address the limitations of current therapies and significantly improve patient outcomes.http://www.sciencedirect.com/science/article/pii/S259012302500324XGastric cancerH. pyloriSignalling pathwaysNanotechnologyTargeted drug deliveryImaging
spellingShingle Smarika Chauhan
Eswar Marcharla
Sneha Hariharan
Saranya Vinayagam
Thanigaivel Sundaram
Priya SD
Swamynathan Ganesan
Maximilian Lackner
Insights into the molecular mechanisms and nanoparticle-based therapies for gastric cancer: A review
Results in Engineering
Gastric cancer
H. pylori
Signalling pathways
Nanotechnology
Targeted drug delivery
Imaging
title Insights into the molecular mechanisms and nanoparticle-based therapies for gastric cancer: A review
title_full Insights into the molecular mechanisms and nanoparticle-based therapies for gastric cancer: A review
title_fullStr Insights into the molecular mechanisms and nanoparticle-based therapies for gastric cancer: A review
title_full_unstemmed Insights into the molecular mechanisms and nanoparticle-based therapies for gastric cancer: A review
title_short Insights into the molecular mechanisms and nanoparticle-based therapies for gastric cancer: A review
title_sort insights into the molecular mechanisms and nanoparticle based therapies for gastric cancer a review
topic Gastric cancer
H. pylori
Signalling pathways
Nanotechnology
Targeted drug delivery
Imaging
url http://www.sciencedirect.com/science/article/pii/S259012302500324X
work_keys_str_mv AT smarikachauhan insightsintothemolecularmechanismsandnanoparticlebasedtherapiesforgastriccancerareview
AT eswarmarcharla insightsintothemolecularmechanismsandnanoparticlebasedtherapiesforgastriccancerareview
AT snehahariharan insightsintothemolecularmechanismsandnanoparticlebasedtherapiesforgastriccancerareview
AT saranyavinayagam insightsintothemolecularmechanismsandnanoparticlebasedtherapiesforgastriccancerareview
AT thanigaivelsundaram insightsintothemolecularmechanismsandnanoparticlebasedtherapiesforgastriccancerareview
AT priyasd insightsintothemolecularmechanismsandnanoparticlebasedtherapiesforgastriccancerareview
AT swamynathanganesan insightsintothemolecularmechanismsandnanoparticlebasedtherapiesforgastriccancerareview
AT maximilianlackner insightsintothemolecularmechanismsandnanoparticlebasedtherapiesforgastriccancerareview